As of 2026-04-03, the EV/EBITDA ratio of China Wah Yan Healthcare Ltd (648.HK) is 82.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 648.HK's latest enterprise value is 553.62 mil HKD. 648.HK's TTM EBITDA according to its financial statements is 6.70 mil HKD. Dividing these 2 quantities gives us the above 648.HK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 7.0x | 6.4x |
| Forward P/E multiples | 5.3x - 5.7x | 5.4x |
| Fair Price | 0.01 - 0.96 | 0.46 |
| Upside | -96.8% - 284.0% | 85.1% |
| Date | EV/EBITDA |
| 2026-03-27 | 85.82 |
| 2026-03-26 | 85.82 |
| 2026-03-25 | 92.16 |
| 2026-03-24 | 93.75 |
| 2026-03-23 | 82.64 |
| 2026-03-20 | 88.99 |
| 2026-03-19 | 90.58 |
| 2026-03-18 | 88.99 |
| 2026-03-17 | 92.16 |
| 2026-03-16 | 92.16 |
| 2026-03-13 | 85.82 |
| 2026-03-12 | 84.23 |
| 2026-03-11 | 88.99 |
| 2026-03-10 | 92.16 |
| 2026-03-09 | 98.51 |
| 2026-03-06 | 98.51 |
| 2026-03-05 | 93.75 |
| 2026-03-04 | 96.92 |
| 2026-03-03 | 96.92 |
| 2026-03-02 | 96.92 |
| 2026-02-27 | 104.86 |
| 2026-02-26 | 92.16 |
| 2026-02-25 | 96.92 |
| 2026-02-24 | 92.16 |
| 2026-02-23 | 101.68 |
| 2026-02-20 | 78.20 |
| 2026-02-16 | 62.01 |
| 2026-02-13 | 62.65 |
| 2026-02-12 | 65.19 |
| 2026-02-11 | 66.46 |
| 2026-02-10 | 66.14 |
| 2026-02-09 | 66.46 |
| 2026-02-06 | 64.23 |
| 2026-02-05 | 64.87 |
| 2026-02-04 | 65.82 |
| 2026-02-03 | 60.11 |
| 2026-02-02 | 66.14 |
| 2026-01-30 | 68.36 |
| 2026-01-29 | 65.50 |
| 2026-01-28 | 60.43 |
| 2026-01-27 | 59.79 |
| 2026-01-26 | 60.11 |
| 2026-01-23 | 60.11 |
| 2026-01-22 | 61.38 |
| 2026-01-21 | 59.79 |
| 2026-01-20 | 59.79 |
| 2026-01-19 | 60.11 |
| 2026-01-16 | 60.43 |
| 2026-01-15 | 61.06 |
| 2026-01-14 | 60.43 |